NPI registry status
Active
2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1942258306 D.O.
Verify on CMS → Matthew Citron, D.O.
Glaucoma Specialist (Ophthalmology) Physician in Southfield, Michigan.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 356 in Glaucoma Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
10K
Medicare Part D claims · 2K beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · Exceptional
Industry payments
$603.99
16 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Matthew Citron, D.O. reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 10,388 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 10K
- Part D claims, 2023
- 76%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Matthew Citron, D.O.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Matthew Citron, D.O. sits
This provider among glaucoma specialist (ophthalmology) physician peers
Across the 216 glaucoma specialist (ophthalmology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Matthew Citron, D.O. writes more Part D claims than 98% of them and scores higher on MIPS quality than 88% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one glaucoma specialist (ophthalmology) physician peer from a representative sample of 60; the gold marker is Matthew Citron, D.O.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Matthew Citron, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Citron, D.O.?
High performer (top quartile)Primary specialty
Glaucoma Specialist (Ophthalmology) Physician
Medicare Part D claims
10,388 251% vs specialty avg
MIPS final score
100/100 16.9 pts vs avg
Specialty distribution in Michigan
How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Michigan providers
Medicare quality performance, MIPS
Matthew Citron, D.O.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) - 100/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Matthew Citron, D.O. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding D.O. credentials at 29201 TELEGRAPH RD, Southfield, MI, 48034, with a listed phone of (248) 356-0098. NPI 1942258306 was issued on 05/05/2006.
Medicare Part D records for calendar year 2023 show 10,388 prescription claims written by this provider, covering 1,668 Medicare beneficiaries and totaling roughly $683K in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 0.1%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 356 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942258306 |
|---|---|
| Specialty | Glaucoma Specialist (Ophthalmology) Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 05/05/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Avg: 83.1
100
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where Matthew Citron, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Glaucoma Center OF Michigan PC
Southfield, MI
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Citron, D.O.. Source: openpaymentsdata.cms.gov.
Total received
$604
Largest payer
Sight Sciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Michigan MI-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Matthew Citron, D.O.. To verify Matthew Citron, D.O.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Matthew Citron, D.O. - brand share 24.0%
Glaucoma Specialist (Ophthalmology) Physician average
24% brand-name claims vs 76% generic, on 10,388 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
10,388
Total Claims
$683K
Total Drug Cost
1,668
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 19,670
- Total Day Supply
- 570,541
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $445K
- Generic Drug Cost
- $238K
- Opioid Claims
- 14 (0.1% rate)
Patient Demographics
- Average Patient Age
- 74.6 years
- Avg HCC Risk Score
- 1.27
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 125, 65-74: 727, 75-84: 587, 85+: 229
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Matthew Citron, D.O. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
3,687 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
1,484 claims
- Brimonidine Tartrate 1,129
Brimonidine Tartrate
1,129 claims
- Timolol Maleate 913
Timolol Maleate
913 claims
- Prednisolone Acetate 708
Prednisolone Acetate
708 claims
- Dorzolamide Hcl 259
Dorzolamide Hcl
259 claims
- Neomycin-Polymyxin… 179
Neomycin-Polymyxin-Dexameth
179 claims
- Rocklatan 178
Rocklatan
178 claims
| Drug | Claims |
|---|---|
| Latanoprost | 3,687 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,484 |
| Brimonidine Tartrate | 1,129 |
| Timolol Maleate | 913 |
| Prednisolone Acetate | 708 |
| Dorzolamide Hcl | 259 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 179 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 178 |
| Ofloxacin | 160 |
| Lumigan Bimatoprost | 142 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Glaucoma Specialist (Ophthalmology) Physician in MI →
All providers in Michigan →
Compare specialties →
Glaucoma Specialist (Ophthalmology) Physician Overview
How Matthew Citron, D.O. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.
356
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider
Matthew Citron, D.O.'s 10,388 claims are above the specialty average of 2,962.
Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Citron.
Dr. Scott Piette
DO
East Lansing, MI
Dr. Les Siegel
M.D.
Southfield, MI
Dr. Marc Siegel
M.D.
Southfield, MI
Dr. Michael Siegel
MD
Southfield, MI
Dr. Jeffrey Wentzloff
M.D.
Traverse City, MI
Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Michigan medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Glaucoma Specialist (Ophthalmology) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Michigan
Frequently Asked Questions
What is Matthew Citron, D.O.'s specialty? ▼
Matthew Citron, D.O. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in Southfield, Michigan. Credentials: D.O..
How much does Matthew Citron, D.O. prescribe under Medicare Part D? ▼
In 2023, Matthew Citron, D.O. wrote 10,388 Medicare Part D claims totaling $683K in drug costs for 1,668 beneficiaries.
What is Matthew Citron, D.O.'s Medicare quality score? ▼
Matthew Citron, D.O. has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Matthew Citron, D.O. located? ▼
Matthew Citron, D.O. is located at 29201 TELEGRAPH RD, Southfield, MI, 48034. Phone: (248) 356-0098.
What is Matthew Citron, D.O.'s NPI number? ▼
Matthew Citron, D.O.'s National Provider Identifier (NPI) is 1942258306, issued on 05/05/2006.
Does Matthew Citron, D.O. prescribe more brand-name or generic drugs? ▼
Matthew Citron, D.O.'s prescribing is 24% brand-name and 76% generic drugs by claim count, with $445K in brand drug costs.
Does Matthew Citron, D.O. prescribe opioids? ▼
Yes, Matthew Citron, D.O. had 14 opioid claims in 2023 with an opioid prescribing rate of 0.1%.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 356 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does Matthew Citron, D.O. prescribe most often? ▼
Based on 2023 Medicare Part D data, Matthew Citron, D.O.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Citron, D.O. accept Medicare? ▼
Matthew Citron, D.O. appears in CMS Medicare data with 10,388 Part D claims and 1,668 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Citron, D.O.'s credentials? ▼
Matthew Citron, D.O.'s NPI is 1942258306 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.